Aurinia Reports First Quarter 2019 Financial Results and Recent Operational Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss of $0.14/Share
May 14, 2019 4:04 PM EDTAurinia Pharmaceuticals (NASDAQ: AUPH) reported Q1 EPS of ($0.14), versus ($0.18) reported last year.
For earnings history and earnings-related data on Aurinia Pharmaceuticals (AUPH) click here.
... More